Navigation Links
MicroRNAs could increase the risk of amputation in diabetics
Date:1/12/2011

New research has found one of the smallest entities in the human genome, micro-RNA, could increase the risk of limb amputation in diabetic patients who have poor blood flow.

The study by Dr Andrea Caporali and colleagues in Professor Costanza Emanueli's research group in the Regenerative Medicine Section of the School of Clinical Sciences at the University of Bristol was funded by the Medical Research Council and is published online in Circulation: Journal of the American Heart Association.

The research group have shown in an experimental cell study that conditions mimicking diabetes and a lack of blood supply to a tissue increased a particular miRNA (miRNA-503) and impaired the ability of endothelial cells, which line the interior surface of blood vessels. Micro-RNAs (miRNAs) are small sections of ribonucleic acid (RNA) that can inhibit many genes.

Alternatively, slowing down miRNA-503 improved the capability of endothelial cells to duplicate and form into networks of small blood vessels. The researchers showed that microRNA-503 reduces cell growth and prevents the formation of blood vessels by direct binding and inhibition of cyclin E1 and Cdc25 mRNA.

Costanza Emanueli, Professorial Research Fellow in Vascular Pathology & Regeneration, said: "Because each miRNA can regulate many genes, they represent an exciting new target to correct diseases that have complex underlying mechanisms, like diabetes, rather than trying to target one specific gene. Our study is the first to provide evidence for a role of miRNAs in diabetes-induced defects in reparative angiogenesis."

The team subsequently investigated miR-503 and target gene expression in muscular specimens from the amputated ischaemic legs of diabetic patients. As controls, calf biopsies of non-diabetic and non-ischemic patients undergoing saphenous vein stripping were used. In diabetic muscles, miR-503 expression was remarkably higher, and plasma miR-503 levels were also elevated in the diabetic subjects.

Finally, using mouse models of diabetes and limb ischaemia, the researchers found that inhibition of the miRNA-503 (using a "decoy miRNA") could restore-post-ischaemic blood flow recovery. The findings of this study highlight important clinical implications of miR-503 in diabetes-associated vascular complications.

In early diabetes, high blood glucose levels damage blood vessels leading to lack of blood flow (ischaemia). Such ischaemic complications are the leading cause of disease and death in diabetic patients. In limbs, lack of blood flow can result in non-healing ulcers and, in diabetic patients, the ischaemic disease follows an unalterable course and limb amputation is too often the eventual remedy.

Tissues can recover from lack of blood flow by new blood vessel growth (angiogenesis), which restores blood supply to the tissue (reperfusion). However, diabetes harms the restoration of the flow of blood to a previously ischemic tissue, by mechanisms that are not fully understood, and so a better understanding of the molecular mechanisms underpinning diabetes-associated vascular complications is urgently needed to improve therapeutic options.


'/>"/>

Contact: Joanne Fryer
joanne.fryer@bristol.ac.uk
44-117-331-7276
University of Bristol
Source:Eurekalert

Related medicine news :

1. Caltech biologists discover microRNAs that control function of blood stem cells
2. Baby-led weaning is feasible but could cause nutritional problems for minority of infants
3. Optimism Could Help Kids Keep Depression at Bay
4. Pandemic flu strain could point way to universal vaccine
5. Link between signaling molecules could point way to therapies for epilepsy, stroke, other diseases
6. Infant Organ Donors Could Help Meet Transplant Needs: Study
7. Thermostatic mixer valves could significantly reduce the risk of scalding in children, study finds
8. Biological joints could replace artificial joints soon
9. Scientists Aim for Test That Could Spot Single Cancer Cell in Blood
10. Maybe Scrooge Couldnt Help Being Hard-Hearted
11. Could Santas Lack of Sleep on Christmas Eve Harm His Health?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... ... Journal, patients report dissatisfaction with numerous issues related to medical care in the ... billing, and poor bedside manner from hospital staff. Commenting on this article, the ...
(Date:5/3/2016)... ... ... In April, Amerec launched a new website designed with optimal user experience ... and sauna solutions. , First, the Amerec website has been redesigned to be easier ... site’s features, especially the Steam Builder Tool , to both mobile and desktop ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... presented its 2016 Champion Award to Charles D. Pulido, R.Ph., Co-Founder of NCPDP ... Pharm.D., M.S., Ph.D., Pharmacy Advisor and Health IT Specialist, Office of the National ...
(Date:5/3/2016)... ... 2016 , ... Sue Desmond-Hellmann, chief executive officer of the Bill & Melinda ... human possibility in her keynote address at Georgia State University’s spring commencement ... her rich experience as a scientist, physician and executive, Desmond-Hellmann leads the Gates Foundation’s ...
(Date:5/3/2016)... ... May 03, 2016 , ... Healing Cancer in This Century ... their families move toward recovery and is offered by creator and visionary Carlos Caridad. ... Francis Talk Radio show considering medical and healing modalities of the fields of ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016  Marking its ... accessible breast and ovarian cancer risk test, ... analyzing 30 genes that highly impact the most ... Available today, the Color Test analyzes hereditary cancer ... stomach, and uterine cancers. The Color Test is ...
(Date:4/28/2016)... 28, 2016  The blood testing market in ... to Kalorama Information and The Freedonia Group in a ... acid testing.  The healthcare research firm said that ... blood collection stations and in improving testing at the ... report, Blood Testing Market in China ...
(Date:4/28/2016)... 28, 2016 , Net Sales of $1.90 ... over the prior year period, and an increase of 1.2% ... Diluted EPS for the first quarter were $0.52 reported, a ... adjusted, an increase of 29.9% over the prior year period ... earnings guidance for 2016 Zimmer Biomet Holdings, Inc. ...
Breaking Medicine Technology: